Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment

Abstract

Online adapted radiotherapy may reduce the dose to organs at risk in high-risk prostate cancer patients, due to reduced PTV margins. This potentially translates to significant reductions in the risks of acute and late adverse effects.